Skip to content

Resuscitation Quick Actions • First 2 Minutes

High-Acuity

4-Hour Toxic Threshold

Serum APAP concentration >= 150 mcg/mL at 4 hours post-ingestion mandates immediate N-Acetylcysteine (NAC) therapy

8-Hour Golden Window

Initiating NAC within 8 hours of ingestion prevents hepatotoxicity in > 99% of cases; if > 8 hours have elapsed, start NAC stat without waiting for labs

IV NAC 3-Bag Protocol

Load: 150 mg/kg IV over 60 min -> 2nd bag: 50 mg/kg IV over 4 hours -> 3rd bag: 100 mg/kg IV over 16 hours (total 300 mg/kg over 21 hours)

NAC Stopping Criteria

Do NOT stop NAC after 21 hours if: APAP is still detectable, AST/ALT are elevated/rising, or INR > 1.5 -> Continue 3rd bag infusion (100 mg/kg/16h) until resolved

King's College Criteria

Arterial pH < 7.30 (after resuscitation) OR Triad of (INR > 6.5 + Creatinine > 3.4 mg/dL + Grade III/IV encephalopathy) -> Stat liver transplant consult

NAC Anaphylactoid Reaction

Flushing, urticaria, or mild pruritus occurs in 10-20% (non-IgE histamine release): Pause infusion for 15-30 min, administer diphenhydramine 50 mg IV, then resume at slower rate

Bottom-Line Clinical Pearl

Acetaminophen is the leading cause of acute liver failure in the United States and Europe. In acute single ingestions, obtain a serum APAP concentration at 4 hours post-ingestion (or immediately if presenting > 4 hours) and plot on the Rumack-Matthew nomogram (treatment line begins at 150 mcg/mL at 4 hours). Administering N-Acetylcysteine (NAC) within 8 hours of ingestion provides virtually 100% hepatoprotection against fatal hepatic necrosis; never delay NAC while awaiting lab results in patients presenting > 8 hours post-ingestion or with evidence of transaminitis.

1. Pathophysiology: Metabolism & NAPQI Depletion

At therapeutic doses, approximately 90% of acetaminophen is metabolized via safe hepatic phase II conjugation (glucuronidation and sulfation) into non-toxic metabolites excreted in urine. Less than 5% is metabolized by cytochrome CYP2E1 into the highly reactive, electrophilic, hepatotoxic intermediate N-acetyl-p-benzoquinone imine (NAPQI). Under normal physiological conditions, endogenous hepatic glutathione immediately detoxifies NAPQI into harmless cysteine and mercapturic acid conjugates.

In severe overdose (> 150 mg/kg or > 7.5 to 10 grams in adults), the glucuronidation and sulfation pathways saturate. Shunting through CYP2E1 rapidly depletes hepatic glutathione stores. When glutathione is depleted to < 30% of normal baseline, free unconjugated NAPQI covalently binds to cysteinyl sulfhydryl groups of hepatic cellular proteins and mitochondrial membranes, producing massive oxidative stress, mitochondrial permeability transition pore opening, and centrilobular (Zone 3) hepatic necrosis.

2. Clinical Stages of Acetaminophen Poisoning

Stage & Post-Ingestion TimingClinical Presentation & SymptomsLaboratory Biomarkers & Pathology
Stage 1: Pre-Injury (0.5 to 24 Hours)Anorexia, nausea, vomiting, diaphoresis, general malaise, or completely asymptomatic.Completely normal hepatic enzymes (AST/ALT), normal bilirubin, normal coagulation (PT/INR). Serum APAP concentration is elevated.
Stage 2: Onset of Hepatic Injury (24 to 72 Hours)Resolution of initial gastrointestinal symptoms; onset of right upper quadrant (RUQ) abdominal tenderness, hepatomegaly, and tachycardia.Early elevation of transaminases (AST rises first and fastest, often exceeding 10,000 IU/L), rising PT/INR, mild hyperbilirubinemia, elevated serum creatinine (acute tubular necrosis).
Stage 3: Peak Hepatotoxicity (72 to 96 Hours)Fulminant hepatic failure: marked jaundice, coagulopathy with spontaneous bleeding, hypoglycemia, lactic acidosis, asterixis, acute renal failure, and hepatic encephalopathy progressing to coma and cerebral edema.Peak AST and ALT (> 10,000 to 30,000 IU/L), marked coagulopathy (INR > 5-10), profound hyperbilirubinemia, severe metabolic acidosis with hyperlactatemia. Zone 3 centrilobular necrosis on histopathology.
Stage 4: Recovery or Death (4 to 14 Days)Surviving patients undergo complete clinical recovery over weeks without chronic liver cirrhosis (liver has extraordinary regenerative capacity). Fatalities occur from multiorgan failure, brainstem herniation from cerebral edema, sepsis, or hemorrhage.Gradual normalization of transaminases and coagulation parameters over 7 to 21 days.

3. The Rumack-Matthew Nomogram: Timing Rules & Nuances

The Rumack-Matthew nomogram plots serum acetaminophen concentration against time post-ingestion to predict the risk of severe hepatotoxicity. Strict prerequisites govern its validity:

Rule/Clinical ParameterNomogram RequirementCritical Clinical Caveat & Exception
Timing of Blood DrawDraw initial serum APAP concentration at or after 4 hours post-ingestion.Levels drawn < 4 hours post-ingestion CANNOT be plotted on the nomogram because gastrointestinal absorption and distribution are incomplete. A level drawn at 2 hours must be repeated at 4 hours.
Treatment Line ThresholdThe 'treatment line' (150-line) starts at 150 mcg/mL at 4 hours (990 mcmol/L) and ends at 4.7 mcg/mL at 24 hours.Any concentration falling ON OR ABOVE the 150-line mandates initiation of a full course of N-Acetylcysteine (NAC).
Extended-Release (ER) IngestionsDelayed or prolonged absorption occurs with APAP extended-release or co-ingestion of anticholinergics/opioids.Draw APAP level at 4 hours and repeat at 8 to 12 hours. If either concentration is above the nomogram line, or if the second level is rising, initiate NAC immediately.
Repeated Supratherapeutic Ingestion (RSI)Chronic or subacute ingestions (e.g., patient taking 6-8 grams daily for toothache over 3-4 days).THE NOMOGRAM CANNOT BE USED! Treat with NAC immediately if: APAP > 20 mcg/mL OR any elevation in AST/ALT above normal.
Presentation > 24 Hours Post-IngestionNomogram does not extend beyond 24 hours.Treat with NAC if APAP is detectable OR if transaminases (AST/ALT) are elevated.

4. Antidote Therapy: N-Acetylcysteine (NAC) Protocols

N-Acetylcysteine acts as a glutathione precursor (supplying cysteine), directly conjugates with NAPQI, enhances sulfate conjugation, and serves as an antioxidant and anti-inflammatory free-radical scavenger that improves microcirculatory blood flow even in late-stage fulminant liver failure.

Regimen/PhaseIntravenous (IV) 3-Bag Protocol (Total 300 mg/kg over 21 Hours)Oral (PO) 72-Hour Protocol (Total 1,330 mg/kg over 72 Hours)
Loading Dose150 mg/kg IV in 200 mL D5W infused over 60 minutes.140 mg/kg PO loading dose (dilute 10% or 20% solution to 5% with juice/soda to mask rotten-egg sulfur odor).
Maintenance Phase 150 mg/kg IV in 500 mL D5W infused over 4 hours.70 mg/kg PO every 4 hours for a total of 17 maintenance doses (repeat dose if patient vomits within 1 hour; give ondansetron 8 mg IV).
Maintenance Phase 2100 mg/kg IV in 1,000 mL D5W infused over 16 hours.Continued oral maintenance doses every 4 hours.
End-of-Infusion Stopping CriteriaBefore stopping at 20-21 hours, check APAP level, AST/ALT, and INR: 1. Serum APAP is undetectable (< 10 mcg/mL) 2. AST/ALT are normal or rapidly declining (by > 50%) 3. INR <= 1.3 to 1.5. If criteria are NOT met, CONTINUE the 3rd bag (100 mg/kg over 16h) without interruption!Same laboratory resolution criteria before terminating therapy.

5. King's College Criteria for Emergent Liver Transplantation

In patients who progress to acute liver failure (ALF) despite antidote administration, the King's College Hospital criteria are the most widely validated prognostic guidelines identifying patients with > 80% to 90% expected mortality without emergent orthotopic liver transplantation:

Major CriterionDiagnostic ThresholdClinical Action
Arterial pH CriterionArterial pH < 7.30 measured after adequate fluid resuscitation (regardless of clinical grade of encephalopathy).Immediate emergency alert to regional liver transplant center; list patient for emergent Super-Status 1A organ allocation.
Triple Laboratory/Clinical CriterionPresence of ALL THREE of the following in a 24-hour period: 1. INR > 6.5 (Prothrombin Time > 100 seconds) 2. Serum Creatinine > 3.4 mg/dL (300 mcmol/L) or anuria 3. Grade III or IV Hepatic Encephalopathy (confusion, somnolence, stupor, or coma).Immediate ICU intubation for airway protection and cerebral edema management (hypertonic 3% saline targeting serum Na 145-155 mEq/L; avoid hypoxemia and hypercapnia). Stat transplant transfer.
Hyperlactatemia CriterionArterial Lactate > 3.5 mmol/L at early presentation (>= 4 hours post-ingestion) OR Lactate > 3.0 mmol/L after fluid resuscitation.High predictive value for irreversible mitochondrial destruction and fatal multiorgan failure.

The Arbitrary 21-Hour Discontinuation Trap & Delaying NAC

Never discontinue IV N-Acetylcysteine at the end of the standard 21-hour infusion without rechecking laboratory parameters! Up to 10% of patients with large ingestions or delayed absorption still have toxic circulating APAP or actively evolving hepatic necrosis at 21 hours. Discontinuing NAC while AST/ALT are rising or APAP is detectable allows un-neutralized NAPQI to destroy remaining hepatocytes, converting a reversible injury into fatal hepatic failure. Always obtain an APAP level, transaminases, and INR 4 hours prior to completing the 3rd bag: if AST/ALT are elevated or rising, or APAP is detectable, CONTINUE the 100 mg/kg IV infusion continuously until APAP is undetectable and transaminases are clearly dropping. Furthermore, if a patient presents > 8 hours post-ingestion, START NAC IMMEDIATELY: do not lose precious hepatocytes waiting 2 hours for the laboratory to process the APAP assay.

Board & Shelf Drill 5 Questions • Untimed Tutor Mode

Test Your Acetaminophen Toxicity & Acute Liver Failure Clinical Acumen

Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.